Targeting UBE2T Potentiates Gemcitabine Efficacy in Pancreatic Cancer by Regulating Pyrimidine Metabolism and Replication Stress

已完结 1 由 7566 发布于 2024/1/1 21:39:29

DOI:10.1053/j.gastro.2023.02.025
作者：Xiangyan Jiang , Yong Ma , Tao Wang , Huinian Zhou , Keshen Wang , Wengui Shi , Long Qin , Junhong Guan , Lianshun Li , Bo Long , Jianli Wang , Xiaoying Guan , Huili Ye , Jing Yang , Zeyuan Yu , Zuoyi Jiao
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://www.sciencedirect.com/science/article/pii/S0016508523001646

Elsevier

Abstract：Background AimsAlthough small patient subsets benefit from current targeted strategies or immunotherapy, gemcitabine remains the first-line drug for pancreatic cancer (PC) treatment. Howeve

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:其它数据库The role of national music in education of youth